-
UBE2F-SAG-Mediated Neddylation of RHEB Drives mTORC1 in Live
2026-06-17
This study uncovers RHEB as a direct neddylation substrate of the UBE2F-SAG axis, revealing a mechanism that enhances mTORC1 signaling and accelerates liver tumorigenesis. The findings provide mechanistic insight into post-translational modification networks influencing hepatic cancer progression and point to novel intervention targets.
-
Lactobacillus gasseri Modulates Colitis via NR1I3 and E-cadh
2026-06-17
Qian et al. (2024) provide mechanistic evidence that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by restoring intestinal barrier function, mediated through NR1I3-dependent upregulation of E-cadherin. This advances our understanding of probiotic action in IBD and identifies E-cadherin as a pivotal therapeutic target.
-
Trolox in Pancreatic Organoid Workflows: Protocols & Innovat
2026-06-16
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) is redefining standardization in oxidative injury research and high-throughput antioxidant screening. Discover how APExBIO's Trolox streamlines organoid culture, troubleshooting, and translational assay design.
-
Lambda Protein Phosphatase: Enabling Precision in Circadian
2026-06-16
Explore how Lambda Protein Phosphatase (RNase-free) empowers translational researchers to unravel phosphorylation-dependent mechanisms in circadian biology, with actionable insights for experimental design, antibody validation, and the study of dynamic transcriptional regulation.
-
Weight Loss Restores Intestinal Stretch Regulation of Satiet
2026-06-15
This study demonstrates that intestinal stretch suppresses food intake and improves glucose tolerance independently of GLP-1 signaling, but that obesity impairs these effects. Both dietary and surgical weight loss reverse these impairments, restoring neuronal activation and metabolic responses to gut stretch, with implications for type II diabetes research.
-
Super-Enhancer Regulation of Disulfidptosis in Prostate Canc
2026-06-15
This study uncovers how a specific super-enhancer drives the expression of SLC7A11 via FOXA1, promoting disulfidptosis and tumor progression in prostate cancer. The findings establish a mechanistic basis for targeting the SE/FOXA1/SLC7A11 axis, suggesting new epigenetic intervention points for difficult-to-treat malignancies.
-
Unlocking Next-Gen MS Models: MOG (35-55) and Mechanistic In
2026-06-14
This thought-leadership article explores the strategic use of MOG (35-55), a myelin oligodendrocyte glycoprotein peptide, as the gold standard for experimental autoimmune encephalomyelitis (EAE) modeling in multiple sclerosis research. By integrating recent findings on PARP7-STAT1/2 signaling and actionable protocol guidance, we offer translational researchers a comprehensive, mechanistically informed roadmap for advancing neuroinflammation assays and accelerating therapeutic innovation.
-
Remdesivir (GS-5734): Protocols and Innovations in Antiviral
2026-06-13
Remdesivir (GS-5734) stands out as a versatile, validated tool for RNA virus research, combining nanomolar efficacy with robust protocol flexibility. This guide translates structural and mechanistic advances into actionable workflows, troubleshooting solutions, and future-facing strategies for coronavirus antiviral research and beyond.
-
Cabozantinib (XL184) and Chronic Kinase Pathway Remodeling i
2026-06-12
Explore how Cabozantinib (XL184) drives timescale-dependent phosphoproteomic changes and cell motility adaptation in renal cell carcinoma research. This article uniquely deciphers chronic exposure effects to inform assay design and translational insight.
-
RNA Clean and Concentrator Kit: Precision RNA Purification S
2026-06-12
APExBIO’s RNA Clean and Concentrator Kit transforms enzymatic RNA purification with its fast, high-yield spin column workflow. Ideal for in vitro transcription cleanup, it delivers reproducible, ultra-pure RNA for demanding molecular research applications.
-
IGF2BP3–FZD1/7 Axis Drives Stemness and Carboplatin Resistan
2026-06-11
The referenced study uncovers how IGF2BP3 stabilizes FZD1/7 transcripts, promoting stem-like features and carboplatin resistance in triple-negative breast cancer (TNBC) cells. By elucidating the molecular basis for chemoresistance, this work establishes a new therapeutic axis and provides a rationale for targeting IGF2BP3–FZD1/7 to enhance platinum-based treatment efficacy.
-
Bardoxolone methyl: Optimizing Redox Pathway Modulation Work
2026-06-11
Bardoxolone methyl (CDDO methyl ester) unlocks precise modulation of the Nrf2 and NF-kB pathways, empowering researchers to advance oxidative stress and inflammation models. This article delivers stepwise protocol insights, troubleshooting strategies, and practical integration of redox biology breakthroughs for cancer and kidney disease research.
-
N3-kethoxal: Precision RNA & DNA Structure Probing in Action
2026-06-10
N3-kethoxal empowers high-resolution mapping of RNA and accessible DNA, bringing unprecedented selectivity to nucleic acid structure and interaction studies. Its azide-functionalized chemistry streamlines bioorthogonal labeling, revealing dynamic nucleic acid-protein interactions in both in vitro and in vivo systems.
-
Trolox in Oxidative Injury Research: Applied Workflows & Ass
2026-06-10
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) stands as the gold-standard antioxidant for benchmarking oxidative stress assays, with proven translational impact in neurodegeneration and cancer biology research. Learn how to maximize reproducibility, troubleshoot common pitfalls, and apply the latest mechanistic insights from lipid peroxidation and ferroptosis studies.
-
Plerixafor (AMD3100): CXCR4 Inhibition for Cancer and Stem C
2026-06-09
Plerixafor (AMD3100) is a potent small-molecule CXCR4 antagonist used to inhibit cancer metastasis and mobilize hematopoietic stem cells. High-affinity blockade of the CXCL12/CXCR4 axis positions it as a gold-standard tool in cancer biology and immunology research. Quantitative benchmarks and recent comparative studies inform its protocol deployment and mechanistic boundaries.